EP 1037878 A2 20000927 - METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
Title (en)
METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
Title (de)
METABOTROPE GLUTAMATREZEPTORANTAGONISTEN ZUR BEHANDLUNG VON KRANKHEITEN DES ZENTRALEN NERVENSYSTEMS
Title (fr)
ANTAGONISTES DES RECEPTEURS DU GLUTAMATE METABOTROPES, UTILISES POUR LE TRAITEMENT DE MALADIES DU SYSTEME NERVEUX CENTRAL
Publication
Application
Priority
- US 9824833 W 19981120
- US 6675897 P 19971121
Abstract (en)
[origin: WO9926927A2] The present invention provides compounds, and pharmaceutical compositions containing those compounds, that act as antagonists at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
IPC 1-7
C07D 215/38; C07D 241/44; C07D 277/72; A61K 31/47; A61K 31/495; A61K 31/425
IPC 8 full level
A61K 31/381 (2006.01); A61K 31/4184 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61K 31/428 (2006.01); A61K 31/44 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/4418 (2006.01); A61K 31/445 (2006.01); A61K 31/451 (2006.01); A61K 31/454 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 31/505 (2006.01); A61P 25/00 (2006.01); A61P 43/00 (2006.01); C07C 49/577 (2006.01); C07C 225/04 (2006.01); C07C 233/58 (2006.01); C07C 233/60 (2006.01); C07C 233/65 (2006.01); C07C 311/13 (2006.01); C07C 323/22 (2006.01); C07D 211/52 (2006.01); C07D 213/30 (2006.01); C07D 213/40 (2006.01); C07D 213/55 (2006.01); C07D 213/63 (2006.01); C07D 213/75 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 215/12 (2006.01); C07D 215/20 (2006.01); C07D 215/38 (2006.01); C07D 215/48 (2006.01); C07D 215/54 (2006.01); C07D 217/26 (2006.01); C07D 235/10 (2006.01); C07D 239/42 (2006.01); C07D 241/18 (2006.01); C07D 241/20 (2006.01); C07D 241/42 (2006.01); C07D 241/44 (2006.01); C07D 277/20 (2006.01); C07D 277/44 (2006.01); C07D 277/64 (2006.01); C07D 277/68 (2006.01); C07D 277/70 (2006.01); C07D 277/72 (2006.01); C07D 333/38 (2006.01); C07D 417/04 (2006.01); C07D 491/04 (2006.01); C07D 521/00 (2006.01)
CPC (source: EP)
A61P 25/00 (2017.12); A61P 43/00 (2017.12); C07D 213/81 (2013.01); C07D 213/82 (2013.01); C07D 215/12 (2013.01); C07D 215/20 (2013.01); C07D 215/38 (2013.01); C07D 215/48 (2013.01); C07D 215/54 (2013.01); C07D 217/26 (2013.01); C07D 231/12 (2013.01); C07D 233/56 (2013.01); C07D 241/42 (2013.01); C07D 241/44 (2013.01); C07D 249/08 (2013.01); C07D 277/68 (2013.01); C07D 277/70 (2013.01); C07D 491/04 (2013.01)
Citation (search report)
See references of WO 9926927A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9926927 A2 19990603; WO 9926927 A3 19991021; AU 1531799 A 19990615; AU 2004202776 A1 20040722; AU 2004202776 A2 20040722; AU 2004202776 B2 20080619; AU 771358 B2 20040318; CA 2311131 A1 19990603; CN 1158264 C 20040721; CN 1285820 A 20010228; CN 1554649 A 20041215; EP 1037878 A2 20000927; IL 136250 A0 20010520; IL 136250 A 20061210; JP 2001524468 A 20011204; MX PA00004940 A 20021017; NZ 505207 A 20031031
DOCDB simple family (application)
US 9824833 W 19981120; AU 1531799 A 19981120; AU 2004202776 A 20040617; CA 2311131 A 19981120; CN 200410047499 A 19981120; CN 98813148 A 19981120; EP 98959535 A 19981120; IL 13625000 A 20000521; IL 13625098 A 19981120; JP 2000522085 A 19981120; MX PA00004940 A 19981120; NZ 50520798 A 19981120